Feasibility and toxicity of chemoembolization for children with liver tumors

Journal of Clinical Oncology

Volumn 18, Issue 6, 2000, Pages 1279-1284

  Malogolowkin, Marcio H ^a   Stanley, Philip ^a   Steele, David A ^a   Ortega, Jorge A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE;

ARTICLE; ARTIFICIAL EMBOLISM; CANCER SURVIVAL; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

EID: 0034116137     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.6.1279     Document Type: Article

References (36)

1. Ortega JA, Krailo MD, Haas JE, et al: Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: A report from the Childrens Cancer Study Group. J Clin Oncol 9:2167-2176, 1991
2. Weinblatt ME, Siegel SE, Siegel MM, et al: Preoperative chemotherapy for unresectable primary hepatic malignancies in children. Cancer 50:1061-1064, 1982
3. Exelby PR, Filler RM, Grosfeld JL: Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics surgical section survey-1974. J Pediatr Surg 10:329-337, 1975
4. Clatworthy HW, Schiller M, Grosfeld JL: Primary liver tumors in infancy and childhood. Arch Surg 93:355-359, 1974
5. Quinn JJ, Altman AJ, Robinson HT, et al: Adriamycin and cisplatin for hepatoblastoma. Cancer 56:1926-1929, 1985
6. Israel M, Pregg WJ, Wilkinson PM: Liquid chromatography analysis of Adriamycin and metabolites in biologic fluids. J Liquid Chromatogr 1:799-809, 1978
7. Ninane J, Perilongo G, Stalens JP, et al: Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A SIOP pilot study. Med Pediatr Oncol 19:199-203, 1991
8. O'Grady JG, Poison RJ, Rolles K, et al: Liver transplantation for malignant disease. Ann Surg 207:373-379, 1988
9. Ringe B, Weittekind C, Bechstein WO, et al: The role of liver transplantation in hepatobiliary malignancy. Ann Surg 209:88-98, 1989
10. Koneru B, Cassavilla A, Bowman J, et al: Liver transplantation for malignant tumors. Gastroenterol Clin North Am 17:177-193, 1988
11. Whitington PF, Balistreri WF: Liver transplantation in pediatrics: Indications, contraindications, and pretransplant management. J Pediatr 118:169-177, 1991
12. Fortner JG, Mulcare RJ, Solis A, et al: Treatment of primary and secondary liver cancer by hepatic artery ligation and infusion chemotherapy. Ann Surg 178:162-165, 1973
13. Koudhal G, Funding J: Hepatic artery ligation in primary and secondary hepatic cancer. Acta Chir Scand 138:289-294, 1972
14. Oberfield RA, McCaffrey JA, Polio J, et al: Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 44:414-423, 1979
15. Patt YZ, Mavligit GM, Chuang VP, et al: Percutaneous hepatic arterial infusion (HAI) of mitomycin-C and floxuridine (FUDR): An effective treatment for metastatic colorectal carcinoma in the liver. Cancer 46:261-265, 1980
16. Daniels JR, Sternlicht M, Daniels AM: Collagen chemoembolization: Pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum (II) in porcine liver and rabbit kidney. Cancer Res 48:2446-2450, 1988
17. Yoshioka T, Hashida M, Muranashi S, et al: Specific delivery of mitomycin C to the liver, spleen and lung: Nano-and microspherical carriers of gelatin. Int J Pharm (Amst) 81:131-141, 1981
18. Lorelius LE, Benedetto AR, Blumhardt R, et al: Enhanced drug retention in VX2 tumors by use of degradable starch microspheres. Invest Radiol 19:212-215, 1984
19. Ensminger WD, Gyves JW, Stetson P, et al: Phase I study of hepatic arterial degradable starch microspheres and mitomycin. Cancer Res 45:4464-4467, 1985
20. Venook AP, Stagg RJ, Lewis BJ, et al: Chemoembolization for hepatocellular carcinoma. J Clin Oncol 8:1108-1114, 1990
21. Shibata J, Fujiyama S, Sato T, et al: Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 64:1586-1594, 1989
22. Ogita S, Tokiwa K, Taniguchi H, et al: Intraarterial chemotherapy with lipid contrast medium for hepatic malignancies in infants. Cancer 60:2886-2890, 1987
23. Sue K, Ikeda K, Nakagawara A, et al: Intrahepatic arterial injections of cisplatin-phosphatidylcholine-lipiodol suspension in two unresectable hepatoblastoma cases. Med Pediatr Oncol 17:496-500, 1989
24. Nakagawa N, Cornelius A, Kao SC, et al: Transcatheter oily chemoembolization for unresectable malignant liver tumors in children. J Vasc Interv Radiol 4:353-358, 1993
25. Group d'Etude et de Traitement du Carcinome Hepatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332: 1256-1261, 1995
26. Rose DM, Chapman WC, Brockenbrough AT, et al: Transcatheter arterial chemoembolization as primary treatment for hepatocellular carcinoma. Am J Surg 177:405-410, 1999
27. Gattoni F, Cornalba G, Brambilla G, et al: Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization: A multicentric study. Radiol Med 95:362-368, 1998
28. Tellez C, Benson AB, Lyster MT, et al: Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer 82:1250-1259, 1998
29. Taschieri AM, Elli M, Cristaldi M, et al: Hepatocarcinoma: Considerations on surgical treatment in a personal series of 23 patients. Hepatogastroenterology 46:2500-2503, 1999
30. Raoul JL: Is chemoembolization of value in inoperable primary hepatocellular carcinoma. HPB Surg 10:406-408, 1998
31. Fan J, Tang ZY, Yu YQ, et al: Improved survival with resection after transcatheter arterial embolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 15(6):674-678, 1998
32. Harnois DM, Steers J, Andrews JC, et al: Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. Liver Transpl Surg 5:192-199, 1999
33. Allagaier HP, Deibert P, Olschewski M, et al: Survival benefit of patients with inoperable hepatocellular carcinoma treated by combination of transarterial chemoembolization and percutaneous ethanol injection: A single-center analysis including 132 patients. Int J Cancer 79:601-605, 1998
34. Palma LD: Diagnostic imaging and interventional therapy of hepatocellular carcinoma. Br J Radiol 71:808-818, 1998
35. Troisi R, Defreyne L, Hesse UJ, et al: Multimodal treatment for hepatocellular carcinoma on cirrhosis: The role of chemoembolization and alcoholization before liver transplantation. Clin Transplant 12:313-319, 1998
36. Raoul JL, Heresbach D, Bretagne JF, et al: Chemoembolization of hepatocellular carcinomas: A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 70:585-590, 1992